Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 60219-1467

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 60219-1467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 1)

This text provides a table showing Odds Ratios with their corresponding 95% confidence intervals displayed on a logarithmic scale based on several studies by Lee et al. (1987), Paul et al. (1989), WHO (1991), Shapiro et al. (2000), and Li et al. (2012). The table contains information about the Odds Ratios for different groups, including all subjects and those using DMPA for over 12 months. The text clarifies that an Odds Ratio greater than 1 indicates an increased risk for DMPA use.*

FDA Label Image

Structure (Medroxyprogesterone Acetate Injectable Suspensionu 2)

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 3)

This text provides information on different methods of birth control, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, avoiding sex during fertile days, spermicide, withdrawal, and not using any birth control method. It also mentions the varying rates of pregnancies per 100 women in one year based on the method used.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 4)

This description provides information about a contraceptive injection containing medroxyPROGESTERone Acetate Injectable Suspension in a single-dose vial. The text includes dosing and usage instructions, details on shaking before use, manufacturer information by Amneal Pharmaceuticals LLC in India, and expiration date. The product is intended for intramuscular use only. The specific lot number is also provided.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 5)

This text appears to be a description of a medication in the form of an injectable suspension containing medroxyPROGESTERone acetate. The medication is for intramuscular use only and is used as a contraceptive injection. The dosage is 150mg per mL. The text also includes information about the storage conditions of the medication and the manufacturer details. It is important to follow the accompanying instructions and consult a healthcare professional before use.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 6)

This text focuses on a contraceptive injection in the form of medroxyprogesterone acetate for intramuscular use. It provides information on the dosage, composition, and administration of the injection, which comes in single-dose vials. The text also includes important details such as the product's purpose, recommended usage, and storage instructions. It serves as a guide for healthcare professionals and individuals seeking information about this specific contraceptive method.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.